Embedded Files
Prototype-stage platform | Early collaboration model | NDA-friendly discussions
Tell us about your biological objective, desired endpoints, and study format.
TissueGenix works with qualified partners on early-access pilot studies for liver and oncology applications using precision bioprinted human tissue workflows in standard multiwell plates. Detailed study specifications and data packages are shared based on partner discussions.
How we work with partners
Feasibility
Align on biological objective, assay goals, study format.Pilot study
Paid pilot project to establish workflow feasibility, assay fit, and initial readouts.Expansion
Extended studies, broader assay packages, and additional tissues or indications as fit develops.
Platform Capabilities
In-plate precision bioprinting
High-cell-density tissue builds
Multicellular and multilayer architecture
Immune cell incorporation
Fast design-to-assay workflow
Readouts & Analysis
Plate-based readouts
Immunostaining and 3D imaging
Multicolored flow cytometry
Transcriptomic analysis: bulk/scRNA-seq
ML-supported phenotyping & QC reporting
Why collaborate with TissueGenix
Multidisciplinary research team
Fast design-to-assay
Well-to-well consistency
Plate-native workflow fit
AL-enabled analysis in development
Page updated
Google Sites
Report abuse